4D Molecular Therapeutics, Inc.

NasdaqGS:FDMT Stock Report

Market Cap: US$198.2m

4D Molecular Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of FDMT?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,805,2703.67%
Hedge Funds2,670,6425.43%
VC/PE Firms7,517,23815.3%
Institutions37,204,33975.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 88.87% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.6%
BlackRock, Inc.
4,921,321US$21.1m1.08%no data
9.86%
RA Capital Management, L.P.
4,564,867US$19.5m-10.5%0.26%
8.27%
Goldman Sachs Group, Investment Banking and Securities Investments
3,828,836US$16.4m18.5%0.01%
6.38%
VR Adviser, LLC
2,952,371US$12.6m-32.9%0.98%
6.18%
The Vanguard Group, Inc.
2,860,508US$12.2m3.35%no data
5.77%
BVF Partners L.P.
2,670,642US$11.4m-63.8%0.43%
4.86%
Janus Henderson Group plc
2,252,240US$9.6m-28.2%no data
3.8%
Morgan Stanley, Investment Banking and Brokerage Investments
1,758,593US$7.5m5.37%no data
3.58%
David Kirn
1,659,153US$7.1m0%no data
3.24%
Novo Holdings A/S
1,500,000US$6.4m0%0.01%
3.07%
Millennium Management LLC
1,420,723US$6.1m1,610%no data
2.65%
Braidwell LP
1,225,448US$5.2m0%0.25%
2.58%
Redmile Group, LLC
1,196,910US$5.1m-5.16%0.36%
2.48%
Casdin Capital, LLC
1,150,000US$4.9m0%0.35%
2.4%
State Street Global Advisors, Inc.
1,112,723US$4.8m-47.4%no data
2.19%
Geode Capital Management, LLC
1,012,162US$4.3m-2.35%no data
1.72%
ArrowMark Colorado Holdings, LLC
794,598US$3.4m-1.11%0.05%
1.41%
Assenagon Asset Management S.A.
653,530US$2.8m-57.7%no data
1.32%
Deep Track Capital, LP
609,900US$2.6m-85.1%0.09%
1.31%
Citadel Advisors LLC
605,092US$2.6m374%no data
1.14%
JPMorgan Chase & Co, Brokerage and Securities Investments
529,093US$2.3m8,800%no data
1.08%
Norges Bank Investment Management
500,823US$2.1m0%no data
1%
Point72 Asset Management, L.P.
464,722US$2.0m1,190%no data
0.99%
Healthcare of Ontario Pension Plan
459,000US$2.0m0%no data
0.96%
Goldman Sachs Asset Management, L.P.
446,137US$1.9m24.1%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/14 22:22
End of Day Share Price 2025/03/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

4D Molecular Therapeutics, Inc. is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Huidong WangBarclays
Konstantinos BiliourisBMO Capital Markets Equity Research
Daniel GiraldoBofA Global Research